
26.68 Delayed Data As of Jan 22 | ![]() Today’s Change | 9.24 Today|||52-Week Range 30.13 | +34.92% Year-to-Date |
SECTOR Health Technology | INDUSTRY Biotechnology | MARKET CAP $2.0B |
Myriad Genetics, Inc. 320 Wakara Way Salt Lake City Utah 84108 |
Paul J. Diaz | President, Chief Executive Officer & Director |
R. Bryan Riggsbee | Chief Financial Officer, Treasurer & Executive VP |
Robert Gardner Harrison | Chief Information Officer |
Jerry S. Lanchbury | Chief Scientific Officer |
Clivetty Martinez | Chief Compliance Officer |